SCHEMBL738059

SCHEMBL738059

CN(C(=O)[C@@H](Cc1csc2ccccc12)N(C)C(=O)C(C)(C)N)[C@H](Cc1c[nH]c2ccccc12)NC=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 6/20 0.47
OPRM1 P35372 1/20 0.47
MMP9 P14780 3/20 0.41
MMP8 P22894 3/20 0.41
MMP14 P50281 1/20 0.41
MMP2 P08253 2/20 0.40
TACR1 P25103 2/20 0.39
ECE1 P42892 1/20 0.38
MC4R P32245 1/20 0.38
MC5R P33032 1/20 0.38
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
ACE P12821 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
APAF1 O14727 1/20 0.37
POLB P06746 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL736841 0.88 GHSR (0.61) GHSROPRM1MMP9MMP8MMP14
SCHEMBL737162 0.86 GHSR (0.61) GHSROPRM1MMP9MMP8MMP14
SCHEMBL14615464 0.79 SMN1; SMN2 (0.35) OPRM1MMP9MMP8MMP2TACR1
SCHEMBL14615502 0.79 OPRD1 (0.39) OPRM1MMP9MMP8MMP2TACR1
SCHEMBL739137 0.79 GHSR (0.51) GHSROPRM1MMP9MMP8MMP14
SCHEMBL1743600 0.78 GHSR (0.54) GHSROPRM1MMP9MMP8MMP14
SCHEMBL736819 0.78 OPRM1 (0.47) GHSROPRM1MMP9MMP8MMP2
SCHEMBL737019 0.74 GHSR (0.85) GHSROPRM1MMP9MMP8ACE
SCHEMBL736951 0.74 GHSR (0.85) GHSROPRM1MMP9MMP8ACE
SCHEMBL761728 0.74 CYP2A6 (0.43) OPRM1MMP9MMP8MMP2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131478-A1 Growth Hormone Secretagogues GHSR, GHRHR, GHITM GHSR 1/4885OPRM1 3398/4885MMP9 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.